Profund Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$144.95 - $152.29 $16,524 - $17,361	-114 Reduced 1.33%	8,435 $1.28 Million
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $61,856 - $108,616	-744 Reduced 8.01%	8,549 $1.25 Million
Q1 2022 May 10, 2022	SELL	$110.08 - $142.92 $66,818 - $86,752	-607 Reduced 6.13%	9,293 $1.1 Million
Q4 2021 Feb 08, 2022	SELL	$99.73 - $148.48 $111,797 - $166,446	-1,121 Reduced 10.17%	9,900 $1.36 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $1.09 Million - $1.53 Million	11,021 New	11,021 $1.53 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.